Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Mutation of MEF2A in an Inherited Disorder with Features of Coronary Artery Disease
Lejin Wang,1,2
Chun Fan,1,2
Sarah E. Topol,1
Eric J. Topol,1,3*
Qing Wang1,2*
Abstract:
The early genetic pathway(s) triggering the pathogenesis ofcoronary artery disease (CAD) and myocardial infarction (MI)remain largely unknown. Here, we describe an autosomal dominantform of CAD/MI (adCAD1) that is caused by the deletion of sevenamino acids in transcription factor MEF2A. The deletion disruptsnuclear localization of MEF2A, reduces MEF2A-mediated transcriptionactivation, and abolishes synergistic activation by MEF2A andby the transcription factor GATA-1 through a dominant-negativemechanism. The MEF2A protein demonstrates strong expressionin the endothelium of coronary arteries. These results identifya pathogenic gene for a familial vascular disease with featuresof CAD and implicate the MEF2A signaling pathway in the pathogenesisof CAD/MI.
1 Center for Cardiovascular Genetics, Department of Cardiovascular Medicine, and Center for Molecular Genetics, Department of Molecular Cardiology, Lerner Research Institute, Cleveland Clinic Foundation 2 Department of Molecular Medicine 3 Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH 44195, USA.
* To whom correspondence should be addressed. E-mail: wangq2{at}ccf.org (Q.W.) and topole{at}ccf.org (E.J.T.)
The editors suggest the following Related Resources on Science sites:
Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family.
G. Maiolino, S. Colonna, M. Zanchetta, L. Pedon, T. M. Seccia, M. Cesari, S. Vigili de Kreutzenberg, A. Avogaro, and G. P. Rossi (2011)
European Journal of Cardiovascular Prevention & Rehabilitation
18, 557-560
|Abstract »|Full Text »|PDF »
CAG Repeat Polymorphism of the MEF2A Gene is not Associated With the Risk of Coronary Artery Disease Among Taiwanese.
L.-A. Hsu, C.-J. Chang, M.-S. Teng, Semon Wu, C.-F. Hu, W.-Y. Chang, and Y.-L. Ko (2010)
Clinical and Applied Thrombosis/Hemostasis
16, 301-305
|Abstract »|PDF »
Regulatory polymorphism in transcription factor KLF5 at the MEF2 element alters the response to angiotensin II and is associated with human hypertension.
Y. Oishi, I. Manabe, Y. Imai, K. Hara, M. Horikoshi, K. Fujiu, T. Tanaka, T. Aizawa, T. Kadowaki, and R. Nagai (2010)
FASEB J
24, 1780-1788
|Abstract »|Full Text »|PDF »
Genetics of myocardial infarction: a progress report.
H. Schunkert, J. Erdmann, and N. J. Samani (2010)
Eur. Heart J.
31, 918-925
|Abstract »|Full Text »|PDF »
Novel Roles of GATA1 in Regulation of Angiogenic Factor AGGF1 and Endothelial Cell Function.
C. Fan, P. Ouyang, A. A. Timur, P. He, S.-A. You, Y. Hu, T. Ke, D. J. Driscoll, Q. Chen, and Q. K. Wang (2009)
J. Biol. Chem.
284, 23331-23343
|Abstract »|Full Text »|PDF »
Association and Functional Analyses of MEF2A as a Susceptibility Gene for Premature Myocardial Infarction and Coronary Artery Disease.
I. Guella, V. Rimoldi, R. Asselta, D. Ardissino, M. Francolini, N. Martinelli, D. Girelli, F. Peyvandi, M. Tubaro, P. A. Merlini, et al. (2009)
Circ Cardiovasc Genet
2, 165-172
|Abstract »|Full Text »|PDF »
Angiopoietin-1 Induces Kruppel-like Factor 2 Expression through a Phosphoinositide 3-Kinase/AKT-dependent Activation of Myocyte Enhancer Factor 2.
K. Sako, S. Fukuhara, T. Minami, T. Hamakubo, H. Song, T. Kodama, A. Fukamizu, J. S. Gutkind, G. Y. Koh, and N. Mochizuki (2009)
J. Biol. Chem.
284, 5592-5601
|Abstract »|Full Text »|PDF »
Research Resource: Rapid Recruitment of Temporally Distinct Vascular Gene Sets by Estrogen.
K. K. Schnoes, I. Z. Jaffe, L. Iyer, A. Dabreo, M. Aronovitz, B. Newfell, U. Hansen, G. Rosano, and M. E. Mendelsohn (2008)
Mol. Endocrinol.
22, 2544-2556
|Abstract »|Full Text »|PDF »
MEF2A Sequence Variants in Turkish Population.
S. Gulec, A. Ruchan Akar, and N. Akar (2008)
Clinical and Applied Thrombosis/Hemostasis
14, 465-467
|Abstract »|PDF »
Where Do We Go for Atherothrombotic Disease Genetics?.
S.-M. Brand-Herrmann (2008)
Stroke
39, 1070-1075
|Full Text »|PDF »
Identification of a New Co-factor, MOG1, Required for the Full Function of Cardiac Sodium Channel Nav1.5.
L. Wu, S. L. Yong, C. Fan, Y. Ni, S. Yoo, T. Zhang, X. Zhang, C. A. Obejero-Paz, H.-J. Rho, T. Ke, et al. (2008)
J. Biol. Chem.
283, 6968-6978
|Abstract »|Full Text »|PDF »
Lack of Association Between the MEF2A Gene and Myocardial Infarction.
W. Lieb, B. Mayer, I. R. Konig, I. Borwitzky, A. Gotz, S. Kain, C. Hengstenberg, P. Linsel-Nitschke, M. Fischer, A. Doring, et al. (2008)
Circulation
117, 185-191
|Abstract »|Full Text »|PDF »
USF1 Contributes to High Serum Lipid Levels in Dutch FCHL Families and U.S. Whites With Coronary Artery Disease.
J. C. Lee, D. Weissglas-Volkov, M. Kyttala, J. S. Sinsheimer, A. Jokiaho, T. W.A. de Bruin, A. J. Lusis, M.-L. Brennan, M. M.J. van Greevenbroek, C. J.H. van der Kallen, et al. (2007)
Arterioscler Thromb Vasc Biol
27, 2222-2227
|Abstract »|Full Text »|PDF »
Role of Kruppel-Like Transcription Factors in Endothelial Biology.
Relevance of Genetics and Genomics for Prevention and Treatment of Cardiovascular Disease: A Scientific Statement From the American Heart Association Council on Epidemiology and Prevention, the Stroke Council, and the Functional Genomics and Translational Biology Interdisciplinary Working Group.
D. K. Arnett, A. E. Baird, R. A. Barkley, C. T. Basson, E. Boerwinkle, S. K. Ganesh, D. M. Herrington, Y. Hong, C. Jaquish, D. A. McDermott, et al. (2007)
Circulation
115, 2878-2901
|Abstract »|Full Text »|PDF »
Bone morphogenetic protein-2 acts upstream of myocyte-specific enhancer factor 2a to control embryonic cardiac contractility.
Y.-X. Wang, L.-X. Qian, D. Liu, L.-L. Yao, Q. Jiang, Z. Yu, Y.-H. Gui, T. P. Zhong, and H.-Y. Song (2007)
Cardiovasc Res
74, 290-303
|Abstract »|Full Text »|PDF »
Immunomodulation Strategies for Preventing Vascular Disease of the Brain and Heart: Workshop Summary.
J. Hallenbeck, G. del Zoppo, T. Jacobs, A. Hakim, S. Goldman, U. Utz, A. Hasan, and for the Immunomodulation Workshop Participants (2006)
Stroke
37, 3035-3042
|Abstract »|Full Text »|PDF »
Overrepresentation of rare variants in a specific ethnic group may confuse interpretation of association analyses.
D. Keen-Kim, C. A. Mathews, V. I. Reus, T. L. Lowe, L. D. Herrera, C. L. Budman, V. Gross-Tsur, A. E. Pulver, R. D. Bruun, G. Erenberg, et al. (2006)
Hum. Mol. Genet.
15, 3324-3328
|Abstract »|Full Text »|PDF »
Genetic susceptibility to myocardial infarction and coronary artery disease.
E. J. Topol, J. Smith, E. F. Plow, and Q. K. Wang (2006)
Hum. Mol. Genet.
15, R117-R123
|Abstract »|Full Text »|PDF »
Identification of a CRYAB Mutation Associated with Autosomal Dominant Posterior Polar Cataract in a Chinese Family..
M. Liu, T. Ke, Z. Wang, Q. Yang, W. Chang, F. Jiang, Z. Tang, H. Li, X. Ren, X. Wang, et al. (2006)
Invest. Ophthalmol. Vis. Sci.
47, 3461-3466
|Abstract »|Full Text »|PDF »
Mapping a new genetic locus for X linked retinitis pigmentosa to Xq28..
A Melamud, G-Q Shen, D Chung, Q Xi, E Simpson, L Li, N S Peachey, H Zegarra, S A Hagstrom, Q K Wang, et al. (2006)
J. Med. Genet.
43, e27
|Abstract »|Full Text »|PDF »
Biomarkers of Cardiovascular Disease: Molecular Basis and Practical Considerations.
R. S. Vasan (2006)
Circulation
113, 2335-2362
|Full Text »|PDF »
Cardiovascular Genomics.
M. S. Sabatine, J. G. Seidman, and C. E. Seidman (2006)
Circulation
113, e450-e455
|Full Text »|PDF »
Myospryn Is a Direct Transcriptional Target for MEF2A That Encodes a Striated Muscle, {alpha}-Actinin-interacting, Costamere-localized Protein.
J. T. Durham, O. M. Brand, M. Arnold, J. G. Reynolds, L. Muthukumar, H. Weiler, J. A. Richardson, and F. J. Naya (2006)
J. Biol. Chem.
281, 6841-6849
|Abstract »|Full Text »|PDF »
Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin.
J. M. McCaffery, N. Frasure-Smith, M.-P. Dube, P. Theroux, G. A. Rouleau, Q. Duan, and F. Lesperance (2006)
Psychosom Med
68, 187-200
|Abstract »|Full Text »|PDF »
Control of MEF2 Transcriptional Activity by Coordinated Phosphorylation and Sumoylation.
S. Gregoire, A. M. Tremblay, L. Xiao, Q. Yang, K. Ma, J. Nie, Z. Mao, Z. Wu, V. Giguere, and X.-J. Yang (2006)
J. Biol. Chem.
281, 4423-4433
|Abstract »|Full Text »|PDF »
The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction.
P Gonzalez, M Garcia-Castro, J R Reguero, A Batalla, A G Ordonez, R L Palop, I Lozano, M Montes, V Alvarez, and E Coto (2006)
J. Med. Genet.
43, 167-169
|Abstract »|Full Text »|PDF »
Molecular evidence for arterial repair in atherosclerosis.
R. Karra, S. Vemullapalli, C. Dong, E. E. Herderick, X. Song, K. Slosek, J. R. Nevins, M. West, P. J. Goldschmidt-Clermont, and D. Seo (2005)
PNAS
102, 16789-16794
|Abstract »|Full Text »|PDF »
Transcriptional Regulation of Tissue-Specific Genes by the ERK5 Mitogen-Activated Protein Kinase.
S. J. Sohn, D. Li, L. K. Lee, and A. Winoto (2005)
Mol. Cell. Biol.
25, 8553-8566
|Abstract »|Full Text »|PDF »
MEF2-dependent Recruitment of the HAND1 Transcription Factor Results in Synergistic Activation of Target Promoters.
S. Morin, G. Pozzulo, L. Robitaille, J. Cross, and M. Nemer (2005)
J. Biol. Chem.
280, 32272-32278
|Abstract »|Full Text »|PDF »
Kruppel-Like Factor 2 as a Novel Mediator of Statin Effects in Endothelial Cells.
S. Sen-Banerjee, S. Mir, Z. Lin, A. Hamik, G. B. Atkins, H. Das, P. Banerjee, A. Kumar, and M. K. Jain (2005)
Circulation
112, 720-726
|Abstract »|Full Text »|PDF »
Complex Trait Locus Linkage Mapping in Atherosclerosis: Time to Take a Step Back Before Moving Forward?.
R. L. Pollex and R. A. Hegele (2005)
Arterioscler Thromb Vasc Biol
25, 1541-1544
|Full Text »|PDF »
Recent Advances in Cardiac Development With Therapeutic Implications for Adult Cardiovascular Disease.
J. A. Epstein and M. S. Parmacek (2005)
Circulation
112, 592-597
|Full Text »|PDF »
Tumor Necrosis Factor Alpha-Mediated Reduction of KLF2 Is Due to Inhibition of MEF2 by NF-{kappa}B and Histone Deacetylases.
A. Kumar, Z. Lin, S. SenBanerjee, and M. K. Jain (2005)
Mol. Cell. Biol.
25, 5893-5903
|Abstract »|Full Text »|PDF »
Heritability and a Genome-Wide Linkage Scan for Arterial Stiffness, Wave Reflection, and Mean Arterial Pressure: The Framingham Heart Study.
G. F. Mitchell, A. L. DeStefano, M. G. Larson, E. J. Benjamin, M.-H. Chen, R. S. Vasan, J. A. Vita, and D. Levy (2005)
Circulation
112, 194-199
|Abstract »|Full Text »|PDF »
Myocyte Enhancer Factor 2 Acetylation by p300 Enhances Its DNA Binding Activity, Transcriptional Activity, and Myogenic Differentiation.
K. Ma, J. K. L. Chan, G. Zhu, and Z. Wu (2005)
Mol. Cell. Biol.
25, 3575-3582
|Abstract »|Full Text »|PDF »
Class II Histone Deacetylases: from Sequence to Function, Regulation, and Clinical Implication.
X.-J. Yang and S. Gregoire (2005)
Mol. Cell. Biol.
25, 2873-2884
|Full Text »|PDF »
Association with Class IIa Histone Deacetylases Upregulates the Sumoylation of MEF2 Transcription Factors.
Hairy-related Transcription Factors Inhibit GATA-dependent Cardiac Gene Expression through a Signal-responsive Mechanism.
I. S. Kathiriya, I. N. King, M. Murakami, M. Nakagawa, J. M. Astle, K. A. Gardner, R. D. Gerard, E. N. Olson, D. Srivastava, and O. Nakagawa (2004)
J. Biol. Chem.
279, 54937-54943
|Abstract »|Full Text »|PDF »
Genome-Wide Linkage Scan Identifies a Novel Genetic Locus on Chromosome 5p13 for Neonatal Atrial Fibrillation Associated With Sudden Death and Variable Cardiomyopathy.
C. Oberti, L. Wang, L. Li, J. Dong, S. Rao, W. Du, and Q. Wang (2004)
Circulation
110, 3753-3759
|Abstract »|Full Text »|PDF »
Transcription factor MEF2A mutations in patients with coronary artery disease.
M.R. K. Bhagavatula, C. Fan, G.-Q. Shen, J. Cassano, E. F. Plow, E. J. Topol, and Q. Wang (2004)
Hum. Mol. Genet.
13, 3181-3188
|Abstract »|Full Text »|PDF »
Genetic Basis of Atherosclerosis: Part I: New Genes and Pathways.
A. J. Lusis, A. M. Fogelman, and G. C. Fonarow (2004)
Circulation
110, 1868-1873
|Full Text »|PDF »
Large scale association analysis for identification of genes underlying premature coronary heart disease: cumulative perspective from analysis of 111 candidate genes.
J J McCarthy, A Parker, R Salem, D J Moliterno, Q Wang, E F Plow, S Rao, G Shen, W J Rogers, L K Newby, et al. (2004)
J. Med. Genet.
41, 334-341
|Abstract »|Full Text »|PDF »
Genomics in Sudden Cardiac Death.
D. E. Arking, S. S. Chugh, A. Chakravarti, and P. M. Spooner (2004)
Circ. Res.
94, 712-723
|Abstract »|Full Text »|PDF »
Cardiovascular News.
R. SoRelle (2003)
Circulation
108, e9077-e9078
|Full Text »
Coronary Artery Disease and the MEF2A Transcription Factor.